On this page we presented the PHAS historical earnings date information for PhaseBio Pharmaceuticals. Reviewing that PHAS Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2022, when PHAS posted gaap of -0.230/share. Meanwhile the lowest PHAS historical earnings result was in Q3 2018, when PHAS posted gaap of -10.45/share. Moving to PhaseBio Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2021 when PHAS reported 0.01B in revenue, while the smallest revenue quarter was Q1 2021 when PHAS reported NA in revenue.

For self directed investors doing their due diligence on PHAS or any other given stock, their research can benefit from looking into all of the PhaseBio Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into PhaseBio Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for PHAS. Thanks for visiting, and the next time you need to research PHAS historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.